TORRENT PHARMACEUTICALS
Back to All Ratios
|
TORRENT PHARMACEUTICALS Last 5 Year Price to Cash Earnings (PCE) History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| PCE(x) | 43.86 | 40.45 | 35.72 | 26.66 | 32.88 |
What is the latest Price to Cash Earnings (PCE) ratio of TORRENT PHARMACEUTICALS ?
| Year | Price to Cash Earnings (PCE) |
|---|---|
| Mar2026 | 43.86 |
| Mar2025 | 40.45 |
| Mar2024 | 35.72 |
| Mar2023 | 26.66 |
| Mar2022 | 32.88 |
How is Price to Cash Earnings (PCE) of TORRENT PHARMACEUTICALS Trending?
| Years | Price to Cash Earnings (PCE) | % Change | |
|---|---|---|---|
| Mar2026 | 43.86 | 8.43 | |
| Mar2025 | 40.45 | 13.24 | |
| Mar2024 | 35.72 | 33.98 | |
| Mar2023 | 26.66 | -18.92 | |
| Mar2022 | 32.88 | - | |
Other Financial Ratios of TORRENT PHARMACEUTICALS
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Price to Cash Earnings (PCE) ratio of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹191,531.4 Cr | 3.6% | 3.4% | 36.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹460,696.0 Cr | 0.5% | -4% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,063.0 Cr | 9.1% | 18.2% | 47.1% | Stock Analytics | |
| CIPLA | ₹114,554.0 Cr | -1.2% | -3.3% | -10.8% | Stock Analytics | |
| MANKIND PHARMA | ₹98,598.7 Cr | 0.5% | -7.4% | -7.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,308.6 Cr | -1.4% | 2.9% | -8% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | 3.6% |
3.4% |
36.4% |
| SENSEX | -0.4% |
-0.5% |
-5.8% |
You may also like the below Video Courses